Cargando…
SGCE promotes breast cancer stemness by promoting the transcription of FGF-BP1 by Sp1
Breast cancer stem cells are mainly responsible for poor prognosis, especially in triple-negative breast cancer (TNBC). In a previous study, we demonstrated that ε-Sarcoglycan (SGCE), a type Ⅰ single-transmembrane protein, is a potential oncogene that promotes TNBC stemness by stabilizing EGFR. Here...
Autores principales: | Qiu, Ting, Hou, Lei, Zhao, Lina, Wang, Xinye, Zhou, Zhongmei, Yang, Chuanyu, Zhang, Huifeng, Jiang, Dewei, Jiao, Baowei, Chen, Ceshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641673/ https://www.ncbi.nlm.nih.gov/pubmed/37838174 http://dx.doi.org/10.1016/j.jbc.2023.105351 |
Ejemplares similares
-
SGCE Promotes Breast Cancer Stem Cells by Stabilizing EGFR
por: Zhao, Lina, et al.
Publicado: (2020) -
Angiopoietin-1 promotes triple-negative breast cancer cell proliferation by upregulating carboxypeptidase A4: ANG1-CPA4 axis promotes TNBC progression
por: Liu, Xue, et al.
Publicado: (2023) -
Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROS
por: Wu, Jiao, et al.
Publicado: (2021) -
Population Prevalence of Deleterious SGCE Variants
por: LeDoux, Mark S.
Publicado: (2020) -
Delayed Diagnoses of SGCE Myoclonus-Dystonia
por: Varga, M. Georgeta, et al.
Publicado: (2020)